GMP COMPLIANT Certified CROs

Global CDMO with 30+ years delivering development and manufacturing for biologics, cell therapies, viral vectors, and mRNA across US, European, and Asian facilities.

Munich-headquartered European CDMO providing development and manufacturing of solid oral dosage forms, capsules, and effervescent tablets with 12 GMP manufacturing sites across Europe.

Contract analytical laboratory providing USP dissolution testing, method development, and stability studies for solid oral dosage form characterization under FDA guidelines.

Gene therapy and viral vector CDMO in Columbus, Ohio, with 20+ years of leadership and 500+ GMP drug substance batches produced for rare and ultra-rare disease programs.

Evotec's integrated drug development campus in Verona, Italy, providing DMPK, toxicology, formulation, and clinical manufacturing services as a one-stop discovery-through-Phase II partner.

Dr. Reddy's wholly-owned integrated CRO and CDMO for small molecules and biologics, combining 650+ Indian scientists with GMP manufacturing in the UK, Mexico, and India.

Shanghai campus of BioDuro-Sundia providing integrated discovery and development services including medicinal chemistry, DMPK, biology, and preclinical development for global biotech.

Swiss CDMO providing API synthesis, lipid nanoparticle manufacturing, and peptide production, known for large-scale mRNA lipid supply and complex pharmaceutical intermediates.

Swiss specialty CDMO focused on exclusive custom synthesis and manufacturing of hazardous chemical reactions, energetic compounds, and complex API intermediates for pharma and fine chemical clients.

Korean CDMO providing development and GMP manufacturing of solid oral dosage forms, injectables, and biosimilars, with FDA and EMA-inspected facilities serving global markets.

GLP/GMP-certified European bioanalytical and CMC CRO near Barcelona with four laboratories and 240 experts serving the full pharmaceutical product lifecycle since 2001.

Tel Aviv-based Israeli pharmaceutical group with CDMO division providing contract development and manufacturing of solid, semi-solid, and liquid dosage forms for domestic and export markets.

Tokyo-based CRO and CDMO providing contract manufacturing of injectable formulations, lyophilized products, and sterile fills for Japanese and international pharmaceutical clients.

Nuvisan's Integrated Contract Bioscience facility in Neu-Ulm, Germany, providing preclinical ADME, bioanalysis, and Phase I clinical trials with a 120-bed clinical pharmacology unit.

Jordanian CDMO providing contract manufacturing of solid oral dosage forms, semi-solids, and liquids for export markets across the Middle East, Africa, and CIS countries.

Durham-based CDMO using proprietary ARCUS genome editing technology to develop and manufacture next-generation allogeneic cell and gene therapy programs.

Uppsala-based Swedish CDMO providing pharmaceutical development, manufacturing, and sterile fill-finish services with expertise in complex injectables and lyophilized products.

US-based biomanufacturing CDMO founded in 2020 delivering end-to-end development and manufacturing for biologics, mRNA, and cell and gene therapy across a domestic facility network.

Cell and gene therapy CDMO with purpose-built cGMP facilities in Edinburgh and Hopkinton, Massachusetts, supporting clinical and commercial advanced therapy programs.

SGS's Belgian life sciences hub providing bioanalytical testing, method validation, and quality control services for pharmaceutical and biotech clients from GLP/GMP-certified laboratories.

Global CDMO with integrated small molecule, biologics, and gene therapy manufacturing including proprietary viral vector platforms across the US, Europe, and Asia.

Hyderabad-based Indian CDMO providing integrated drug discovery, development, and manufacturing services with capabilities spanning medicinal chemistry through commercial API supply.

Leading Chinese gene therapy CDMO providing lentiviral, adenoviral, and AAV vector manufacturing services along with custom cell line development for preclinical and clinical-grade production.

Amman-based Jordanian CRO and pharmaceutical company providing bioequivalence studies, BA/BE clinical trials, and contract analytical services for MENA pharmaceutical markets.

Maryland-based cell therapy development company providing iPSC-derived cell therapy manufacturing, process development, and analytical services for clinical-stage gene and cell therapy programs.